Estuary Biotherapeutics has launched after securing $103m in total committed financing for developing targeted gene therapies to treat kidney diseases.The...
USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has initiated a Phase I clinical trial to determine...
Cyrano Therapeutics has reported that the Phase II FLAVOR study of CYR-064 met its primary safety endpoint in patients with...
GE HealthCare has secured CE Mark certification for its MINItrace Magni cyclotron and broadened its PETtrace Solid Target Platform to...
Merz Therapeutics has concluded patient enrolment in MINT-C and MINT-E, two global Phase III clinical trials assessing Xeomin for adult...
Transcripta Bio has entered into a research collaboration and licensing agreement with Mayo Clinic to identify potential treatments and therapeutic...
The US FDA has granted 510(k) clearance to Stryker for Sonopet 3, the medical technology company's latest ultrasonic platform for...
Alentis Therapeutics and PinotBio have entered into a research collaboration and licensing agreement to develop claudin-1-targeting antibody-drug conjugates (ADCs) for...
Pilatus Biosciences has dosed the first patient in Hong Kong, as part of an ongoing Phase I clinical trial assessing...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.